Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
49.30
-0.52 (-1.04%)
May 29, 2026, 4:00 PM EDT - Market closed
Scholar Rock Holding Employees
Scholar Rock Holding had 289 employees as of December 31, 2025. The number of employees increased by 93 or 47.45% compared to the previous year.
Employees
289
Change (1Y)
93
Growth (1Y)
47.45%
Revenue / Employee
n/a
Profits / Employee
-$1,414,277
Market Cap
5.91B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 289 | 93 | 47.45% |
| Dec 31, 2024 | 196 | 46 | 30.67% |
| Dec 31, 2023 | 150 | 36 | 31.58% |
| Dec 31, 2022 | 114 | -31 | -21.38% |
| Dec 31, 2021 | 145 | 26 | 21.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| PTC Therapeutics | 991 |
| Mirum Pharmaceuticals | 418 |
| Rhythm Pharmaceuticals | 414 |
| CRISPR Therapeutics AG | 393 |
| Apogee Therapeutics | 261 |
| Cogent Biosciences | 258 |
| CG Oncology | 142 |
| Protagonist Therapeutics | 131 |
SRRK News
- 4 days ago - Scholar Rock to Present at the Goldman Sachs 47th Annual Global Healthcare Conference - Business Wire
- 10 days ago - Scholar Rock to Present at the 2026 Jefferies Global Healthcare Conference - Business Wire
- 14 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 18 days ago - Scholar Rock Holding Transcript: Bank of America Global Healthcare Conference 2026 - Transcripts
- 21 days ago - Scholar Rock Q1 Earnings Call Highlights - MarketBeat
- 22 days ago - JPMorgan places Scholar Rock on ‘Positive Catalyst Watch’ - TheFly
- 22 days ago - Scholar Rock price target raised to $55 from $53 at Barclays - TheFly
- 22 days ago - Scholar Rock price target raised to $65 from $58 at H.C. Wainwright - TheFly